Turnover: 865 million EUR (2022)
Country: France
- Théa is an independent pharmaceutical laboratory owned by the Chibret family, specializing in the research, development and marketing of ophthalmic products.
- Founded 28 years ago, Théa is today Europe's leading independent ophthalmology pharmaceutical group.
- Headquartered in Clermont-Ferrand, Théa has more than 34 subsidiaries and offices in Europe, Russia, North and South America and the Maghreb.
- More than 1,700 employees and products available in over 75 countries worldwide.
- An independent, family-owned group
News
Théa laboratory expands to La Rochelle 25/07/2023
- The Théa laboratory is building a new plant to produce ophthalmic cataract inserts.
- The plant will meet a 20% to 30% increase in demand.
- Sales of the ophthalmic insert are increasing, as it is used in around 60% of cataract operations.
- The Théa laboratory has been present in the United States for three years, achieving sales of $40 million thanks to the purchase of a Swiss company. Between 2021 and 2022, Théa's sales in the U.S. have increased by 140 million euros.
- Théa has 35 subsidiaries and offices in Europe, North and South America, North Africa and the Middle East, employing over 1,600 people.
- Théa products are available in 75 countries.
- In 2022, Théa recorded sales of 865 million euros.
- Théa's sales forecast for this year is 920 million euros.
Studies mentioning this company
The ophthalmology market - France
Other companies mentioned:
- Nidek France
- US Ophthalmic
- OPKO Health
- Centre Ophtalmologique Saint Paul
- Carl Zeiss Group
- Unither Groupe
- Hôpital des Quinze-Vingts
- Hôpital fondation Adolphe de Rothschild
- Horus Pharma
- Thea Laboratoires groupe
- Carl Zeiss Méditec
- CLSO
- E-ophtalmo
- EBC Europe
- Iris Pharma
- Moria Surgical
- Ophtalys
- Optéolia
- Saargos
- Hoya Corporation
> Besoin de plus d'information sur cette entreprise (SWOT, PESTEL, son marché) ? Demandez à SectorGPT (gratuit)
Sector-GPT est la première IA dédiée aux informations sectorielles.